Publication | Closed Access

Doxebo (doxorubicin-free Doxil-like liposomes) is safe to use as a pre-treatment to prevent infusion reactions to PEGylated nanodrugs

NanomedicineEngineeringMedicineDoxorubicin-free Doxil-like LiposomesPharmaceutical NanotechnologyNano-drug DeliveryInfusion ReactionsBiomedical EngineeringPegylated NanodrugsPharmacologyDrug Discovery